We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App





Inhaled Budesonide Commonly Used to Treat Asthma Significantly Reduces Need for Hospitalization in COVID-19 Patients

By HospiMedica International staff writers
Posted on 11 Feb 2021
Print article
Illustration
Illustration
Early treatment with a medication commonly used to treat asthma appears to significantly reduce the need for urgent care and hospitalization in people with COVID-19, suggests new research.

A study conducted by researchers at the University of Oxford (Oxford, UK) has found that inhaled budesonide given to patients with COVID-19 within seven days of the onset of symptoms also reduced recovery time. Budesonide is a corticosteroid used in the long-term management of asthma and chronic obstructive pulmonary disease (COPD).

The findings from the Phase 2 randomized study that involved 146 people - out of whom half took 800 micrograms of the medication twice a day and half were on usual care - suggest that inhaled budesonide reduced the relative risk of requiring urgent care or hospitalisation by 90% in the 28-day study period. Participants allocated the budesonide inhaler also had a quicker resolution of fever, symptoms and fewer persistent symptoms after 28 days. The study also demonstrated that there was a reduction in persistent symptoms in those who received budesonide.

“There have been important breakthroughs in hospitalized COVID-19 patients, but equally important is treating early disease to prevent clinical deterioration and the need for urgent care and hospitalization, especially to the billions of people worldwide who have limited access to hospital care,” said Professor Mona Bafadhel of the University’s Nuffield Department of Medicine, who led the trial. “The vaccine programs are really exciting, but we know that these will take some time to reach everyone across the world. I am heartened that a relatively safe, widely available and well studied medicine such as an inhaled steroid could have an impact on the pressures we are experiencing during the pandemic.”

“Although not the primary outcome of study, this is an important finding,” said Prof Bafadhel, a Respiratory Consultant working at the Oxford University Hospitals NHS Foundation Trust. “I am encouraged to see the reduction in persistent symptoms at 14 and 28 days after treatment with budesonide. Persistent symptoms after the initial COVID-19 illness have emerged as a long-term problem. Any intervention which could address this would be a major step forward.”

Related Links:
University of Oxford

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Digital Radiographic System
OMNERA 300M
New
Transcatheter Heart Valve
SAPIEN 3 Ultra

Print article

Channels

Surgical Techniques

view channel
Image: Schematic diagram of intra-articular pressure detection using a sensory system in a sheep model (Photo courtesy of Science China Press)

Novel Sensory System Enables Real-Time Intra-Articular Pressure Monitoring

Knee replacement surgery is a widely performed procedure to relieve knee pain and restore joint function, with over one million surgeries conducted annually. However, 10%-20% of patients remain dissatisfied... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.